401 Odcinki

  1. Episode 264: Prostatectomy vs RT vs surveillance- the PROTECT trial

    Opublikowany: 27.09.2023

  2. Episode 263: Toni Choueiri and papillary renal cancer

    Opublikowany: 20.09.2023

  3. Episode 262: Paper of the month abiraterone +/- cabazitaxel in CRPC.

    Opublikowany: 12.09.2023

  4. Episode 261: part 2 ctDNA in bladder cancer

    Opublikowany: 4.09.2023

  5. Episode 260: Celeste Simon: how to make a career in translation science work.

    Opublikowany: 30.08.2023

  6. Episode 259: Cystectomy for bladder cancer

    Opublikowany: 24.08.2023

  7. Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1

    Opublikowany: 15.08.2023

  8. Episode 257: Chana Weinstock from the FDA

    Opublikowany: 7.08.2023

  9. Episode 256: ctDNA in urothelial studies.

    Opublikowany: 27.07.2023

  10. Episode 255: How to get an academic paper accepted

    Opublikowany: 26.07.2023

  11. Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges

    Opublikowany: 17.07.2023

  12. Episode 253: Patients' perspectives on adjuvant and 1st line RCC

    Opublikowany: 13.07.2023

  13. Episode 252: Talazoparib and its FDA approval in CRPC

    Opublikowany: 4.07.2023

  14. Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion

    Opublikowany: 26.06.2023

  15. Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1

    Opublikowany: 18.06.2023

  16. Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer

    Opublikowany: 18.06.2023

  17. Episode 248: ASCO23 GU highlights

    Opublikowany: 14.06.2023

  18. Episode 246: ASCO 2023: EV pembro and erdafitinib +/- cetrelimab in 1st line UC

    Opublikowany: 5.06.2023

  19. Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer

    Opublikowany: 5.06.2023

  20. Episode 244: ASCO 2023 PEACE-1 in CRPC

    Opublikowany: 5.06.2023

8 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site